BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Leonid Timashev does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 EWTXEdgewise Therapeutics Inc | Buy | $48.00 | Jun 2025 | +117.6% | Miss |
 CATXPerspective Therapeutics Inc. | Buy | $16.00 | Jun 2025 | −14.3% | Miss |
| EWTXEdgewise Therapeutics Inc | Buy | $52.00 | Apr 2025 | +175.2% | Miss |
 PYXSPyxis Oncology Inc | Buy | $8.00 | Mar 2025 | +36.0% | Miss |
| EWTXEdgewise Therapeutics Inc | Buy | $56.00 | Mar 2025 | +1.4% | Miss |
 CMPSCompass Pathways Plc | Buy | $18.00 | Jan 2025 | +101.2% | Miss |
| PYXSPyxis Oncology Inc | Buy | $8.00 | Dec 2024 | −42.6% | Miss |
| PYXSPyxis Oncology Inc | Buy | $10.00 | Nov 2024 | +143.5% | Miss |
| CMPSCompass Pathways Plc | Buy | $18.00 | Nov 2024 | +27.0% | Miss |
 BHVNBiohaven Ltd. | Buy | $68.00 | Sep 2024 | −63.1% | Miss |
| EWTXEdgewise Therapeutics Inc | Buy | $42.00 | Sep 2024 | −33.1% | Miss |
| PYXSPyxis Oncology Inc | Buy | $7.00 | Sep 2024 | −28.9% | Miss |
| EWTXEdgewise Therapeutics Inc | Buy | $32.00 | Sep 2024 | −17.0% | Hit |
| BHVNBiohaven Ltd. | Buy | $59.00 | Sep 2024 | −46.9% | Miss |
| PYXSPyxis Oncology Inc | Buy | $7.00 | Mar 2024 | −70.1% | Miss |
| PYXSPyxis Oncology Inc | Buy | $7.00 | Sep 2023 | +37.0% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.